Serina Therapeutics (SER) Prepaid Assets (2017 - 2026)
Serina Therapeutics' (SER) quarterly Prepaid Assets came in at $2.0 million in Q2 2026, up 2.87% year-over-year from $2.0 million in Q2 2025, and down 33.66% quarter-over-quarter from $3.0 million in Q4 2025.
Analysis
Serina Therapeutics (SER) Prepaid Assets (2017 - 2026) Analysis & Trends
Serina Therapeutics has disclosed Prepaid Assets across 10 years of filings, most recently posting $2.0 million for Q2 2026.
- In Q2 2026, Prepaid Assets rose 2.87% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $2.0 million (up 2.87% YoY), while the FY2025 annual figure was $3.0 million, up 50.9% from the prior year.
- Prepaid Assets came in at $2.0 million for Q2 2026 at Serina Therapeutics, down from $3.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.0 million in Q4 2025 to a low of $166000.0 in Q1 2024.
- Average Prepaid Assets over 5 years is $1.7 million, with a median of $1.6 million recorded in 2022.
- Year-over-year, Prepaid Assets plunged 88.64% in 2024 and soared 795.78% in 2025.
- Over 5 years, Prepaid Assets stood at $1.8 million in 2022, then sank by 62.69% to $673000.0 in 2023, then jumped by 197.77% to $2.0 million in 2024, then soared by 50.9% to $3.0 million in 2025, then slumped by 33.66% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $2.0 million in Q2 2026, $3.0 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.88 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 166,000.00 |
| Sep 30, 2023 | 673,000.00 |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 720,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 720,000.00 |
| Jun 30, 2021 | 930,000.00 |
| Mar 31, 2021 | 1.29 Mn |